Lawyers lay out how the CJEU decision has provided some clarity on SPC law but raised confusion around the terms ‘developed’ and ‘independent’ After last week’s Royalty Pharma decision from the EU’s ...
EQS-News: APONTIS PHARMA AG / Key word(s): Preliminary Results/Annual Results APONTIS PHARMA with successful financial year 2022: Revenue and EBITDA forecast slightly exceeded according to preliminary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results